Technical Analysis for BDSI - BioDelivery Sciences International, Inc.

Grade Last Price % Change Price Change
grade C 4.6 -1.92% -0.09
BDSI closed down 1.92 percent on Friday, September 20, 2019, on 1.11 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Down
See historical BDSI trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
New Uptrend Bullish -1.92%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.92%
180 Bullish Setup Bullish Swing Setup -3.97%
NR7 Range Contraction -3.97%
Upper Bollinger Band Walk Strength -3.97%
Overbought Stochastic Strength -3.97%
Bearish Engulfing Bearish -2.54%
Upper Bollinger Band Walk Strength -2.54%
Overbought Stochastic Strength -2.54%

Older signals for BDSI ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapeutics in the areas of pain management and oncology supportive care. The company uses its patented BioErodible MucoAdhesive (BEMA) drug delivery technology that consists of a small, bi-layered erodible polymer film for application to the buccal mucosa in the development of its products. Its products include ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in opioid tolerant adult patients with cancer; BEMA Buprenorphine that is in Phase III trial for the treatment of moderate to severe chronic pain in a mixed opioid naïve and opioid experienced population; BEMA Buprenorphine/Naloxone, which is in development stage for the treatment of opioid dependence; and BEMA Granisetron for the prevention of nausea and vomiting associated with cancer therapies. The company has a licensing and development agreement with Endo Pharmaceuticals, Inc. to develop and commercialize BEMA Buprenorphine. BioDelivery Sciences International, Inc. was founded in 1997 and is headquartered in Raleigh, North Carolina.
Cancer Pharmaceutical Pain Drugs Pain Management Euphoriants Cancer Therapies Morphinans Opioids Nausea Vomiting Fentanyl Severe Chronic Pain Buprenorphine Drug Delivery Technology Drug Rehabilitation Opioid Opioid Antagonists Breakthrough Pain Naloxone
Is BDSI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 5.3732
52 Week Low 2.65
Average Volume 677,419
200-Day Moving Average 4.3953
50-Day Moving Average 4.205
20-Day Moving Average 4.5105
10-Day Moving Average 4.698
Average True Range 0.1586
ADX 26.08
+DI 28.1913
-DI 16.6689
Chandelier Exit (Long, 3 ATRs ) 4.4542
Chandelier Exit (Short, 3 ATRs ) 4.5358
Upper Bollinger Band 4.9324
Lower Bollinger Band 4.0886
Percent B (%b) 0.61
BandWidth 18.70746
MACD Line 0.1369
MACD Signal Line 0.1341
MACD Histogram 0.0028
Fundamentals Value
Market Cap 255.18 Million
Num Shares 55.5 Million
EPS 0.03
Price-to-Earnings (P/E) Ratio 153.33
Price-to-Sales 3.69
Price-to-Book 6.22
PEG Ratio 0.98
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.81
Resistance 3 (R3) 4.82 4.77 4.78
Resistance 2 (R2) 4.77 4.71 4.76 4.76
Resistance 1 (R1) 4.68 4.68 4.66 4.67 4.75
Pivot Point 4.63 4.63 4.61 4.62 4.63
Support 1 (S1) 4.54 4.57 4.52 4.53 4.45
Support 2 (S2) 4.49 4.54 4.48 4.44
Support 3 (S3) 4.40 4.49 4.43
Support 4 (S4) 4.39